Quick Answer
FILANA THERAPEUTICS, INC. reported Earnings Per Share Diluted of $1.88 (loss) per share for the year ending 2025.
- FILANA THERAPEUTICS, INC. showed a decrease of -28.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from FILANA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2011 to 2025), FILANA THERAPEUTICS, INC.'s Earnings Per Share Diluted has declined by 3,033.3%.
- Historical annual values: Fiscal year 2025: $1.88 (loss) per share | Fiscal year 2024: $1.46 (loss) per share | Fiscal year 2023: $2.32 (loss) per share | Fiscal year 2022: $1.90 (loss) per share | Fiscal year 2015: $0.31 (loss) per share | Fiscal year 2014: $0.27 (loss) per share | Fiscal year 2013: $0.70 per share | Fiscal year 2012: $0.08 (loss) per share | Fiscal year 2011: $0.06 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: